GO:0005801 cis-Golgi network: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005801 (cis-Golgi network) is the interconnected tubular and cisternal network at the convex (cis) side of the Golgi apparatus, abutting the endoplasmic reticulum.
• It is the first Golgi station for newly synthesized secretory cargo and a hub for glycosylation, sorting, and microtubule-dependent positioning.
• The cis-Golgi network is dynamic: in plants it forms an intermediate tubular network that receives ER-derived cargo, and in mammals it is organized by coiled-coil tethers such as TUG and GMAP-210.
• Key proteins include GMAP-210 (TRIP11), TUG (ASPSCR1), golgins, COPI/COPII machinery, and glycosyltransferases.
• Defects in cis-Golgi network components are linked to mucolipidoses and other glycosylation disorders.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect cis-Golgi network gene function and disease mechanisms.
Description
The cis-Golgi network (CGN), defined by the Gene Ontology as GO:0005801, is the network of interconnected tubular and cisternal structures located at the convex side of the Golgi apparatus, which abuts the endoplasmic reticulum. As the entry point of the secretory pathway, the CGN receives cargo from the ER and initiates the ordered series of modifications and sorting events that define Golgi function. Its unique position makes it a critical hub for membrane trafficking, glycosylation, and cellular homeostasis. Research on the CGN spans plant and animal systems. In plants, the cis-Golgi network forms a dynamic intermediate tubular network that mediates ER-to-Golgi trafficking. In mammals, the CGN is associated with peripheral proteins such as GMAP-210, a minus-end microtubule-binding protein that helps position the Golgi. The CGN also concentrates specific machinery, including tethering factors like TUG, which organize the early secretory pathway. Because the CGN is the first Golgi compartment encountered by secretory cargo, its dysfunction can broadly impact protein glycosylation and trafficking, with consequences for human disease. Understanding its components, assembly, and regulation is therefore central to cell biology and translational research.
cis-Golgi network At A Glance
| GO ID | GO:0005801 |
|---|---|
| GO term | cis-Golgi network |
| Ontology | cellular_component |
| Synonym | cis face, cis Golgi network, forming face, Golgi cis face, Golgi cis-face |
| Definition | The network of interconnected tubular and cisternal structures located at the convex side of the Golgi apparatus, which abuts the endoplasmic reticulum. |
| Major function | Entry point for ER-to-Golgi cargo; glycosylation, sorting, and microtubule-dependent positioning. |
| Key proteins | GMAP-210 (TRIP11), TUG (ASPSCR1), golgins, COPI/COPII components, glycosyltransferases. |
| Related disease | Mucolipidoses and other glycosylation disorders. |
What Is GO:0005801?
The cis-Golgi network (GO:0005801) is the collection of interconnected tubular and cisternal membrane structures at the convex (cis) face of the Golgi apparatus, the side that faces and abuts the endoplasmic reticulum. It is synonymous with the cis face, cis Golgi network, forming face, Golgi cis face, and Golgi cis-face. Functionally, it serves as the first Golgi compartment for secretory cargo and is enriched in proteins that mediate tethering, sorting, and glycosylation.
Why Is cis-Golgi network Important in Cell Biology?
The cis-Golgi network is essential because it is the first Golgi station for the entire secretory pathway, and its organization determines how proteins and lipids are modified, sorted, and dispatched to their destinations. Its dysfunction can lead to defects in glycosylation and trafficking, which underlie a range of human diseases including mucolipidoses. Moreover, the CGN is a dynamic structure whose assembly and positioning depend on microtubules and tethering factors, making it a model system for studying organelle biogenesis and membrane traffic.
• Serves as the entry point for ER-to-Golgi cargo, initiating Golgi glycosylation.
• Contains GMAP-210, a minus-end microtubule-binding protein that helps position the Golgi.
• Organized by tethering factors such as TUG, which coordinate early secretory pathway assembly.
• In plants, forms a dynamic intermediate tubular network for ER-to-Golgi trafficking.
• Dysfunction is linked to mucolipidoses and other glycosylation disorders.
• Provides a platform for studying COPI/COPII vesicle trafficking and Golgi homeostasis.
• Its peripheral proteins redistribute upon brefeldin A treatment, revealing dynamic regulation.
• Critical for understanding how cells maintain organelle identity and secretory capacity.
• A target for CRISPR screens to identify novel regulators of secretion.
• Relevant to cancer and neurodegeneration through altered glycosylation and trafficking.
What Happens During cis-Golgi network?
Cargo reception from the endoplasmic reticulum
In simple terms: The cis-Golgi network is the first stop for proteins leaving the ER.
Newly synthesized secretory proteins exit the ER in COPII vesicles and fuse with the cis-Golgi network, the first Golgi compartment. In plants, this delivery occurs through a dynamic intermediate cis-Golgi tubular network that connects the ER and Golgi. The CGN then sorts cargo for further Golgi processing or retrograde transport.
Glycosylation initiation
In simple terms: The cis-Golgi network starts adding sugar chains to proteins.
The cis-Golgi network is enriched in glycosyltransferases that initiate and extend N- and O-linked glycans on secretory cargo. These modifications are essential for protein folding, stability, and function, and defects in these enzymes cause glycosylation disorders.
Microtubule-dependent positioning
In simple terms: The cis-Golgi network is held in place by interactions with the cytoskeleton.
GMAP-210, a cis-Golgi network-associated protein, binds to the minus ends of microtubules and helps position the Golgi apparatus near the centrosome. This positioning is critical for efficient secretion and is regulated by cell cycle and signaling cues.
Tethering and fusion machinery
In simple terms: Tethering proteins help vesicles dock and fuse at the cis-Golgi network.
The CGN contains coiled-coil tethering proteins such as TUG (ASPSCR1) that organize the early secretory pathway. These tethers, along with golgins and COPI/COPII components, ensure specificity of vesicle fusion and maintain Golgi homeostasis.
Dynamic response to brefeldin A
In simple terms: The cis-Golgi network can redistribute when trafficking is disrupted.
Treatment with brefeldin A causes peripheral cis-Golgi network proteins to redistribute into the intermediate compartment, demonstrating the dynamic nature of this compartment. This response is used experimentally to study Golgi disassembly and reassembly.
Key Genes Involved in GO:0005801 cis-Golgi network
The following genes and proteins are experimentally validated components or regulators of the cis-Golgi network (GO:0005801).
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRIP11 (GMAP-210) | Cis-Golgi network-associated protein; minus-end microtubule-binding protein | Golgi positioning and microtubule organization |
| ASPSCR1 (TUG) | Tethering factor organizing the early secretory pathway | ER-to-Golgi trafficking and Golgi assembly |
| COPA | COPI coatomer subunit; retrograde transport | COPI vesicle trafficking and Golgi homeostasis |
| COPB1 | COPI coatomer subunit; retrograde transport | COPI vesicle trafficking and Golgi homeostasis |
| USO1 (p115) | Tethering factor for ER-to-Golgi vesicles | Vesicle docking and fusion |
| GOLGA2 (GM130) | Golgin; cis-Golgi matrix protein | Golgi structure and positioning |
| GOLGB1 (giantin) | Golgin; Golgi membrane tethering | Golgi ribbon formation |
| BET1 | SNARE protein; intra-Golgi transport | Membrane fusion at the cis-Golgi |
| STX5 | SNARE protein; ER-to-Golgi fusion | Vesicle fusion specificity |
| MAN2A1 | Glycosyltransferase; N-glycan processing | Glycosylation disorders |
| MGAT1 | Glycosyltransferase; N-glycan processing | Glycosylation disorders |
| B4GALT1 | Glycosyltransferase; glycosphingolipid synthesis | Glycosylation and lipid metabolism |
| GNPTAB | GlcNAc-1-phosphotransferase; lysosomal enzyme targeting | Mucolipidosis II/III |
| GNPTG | GlcNAc-1-phosphotransferase subunit; lysosomal enzyme targeting | Mucolipidosis III |
| ARF1 | Small GTPase; COPI recruitment | COPI vesicle formation |
| RAB1A | Small GTPase; ER-to-Golgi transport | Vesicle tethering and fusion |
| RAB2A | Small GTPase; ER-to-Golgi transport | Vesicle tethering and fusion |
How Is cis-Golgi network Regulated?
The cis-Golgi network is regulated by small GTPases such as ARF1 and RAB1, which control COPI/COPII vesicle formation and tethering. GEF-effector interactions ensure spatial and temporal specificity of these GTPases. In plants, the dynamic tubular network of the cis-Golgi is regulated during ER-to-Golgi trafficking. Additionally, the CGN responds to brefeldin A, which causes redistribution of peripheral proteins, indicating regulation by membrane trafficking pathways.
cis-Golgi network and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GNPTAB | Mucolipidosis II/III | Knockout in HeLa or patient fibroblasts |
| GNPTG | Mucolipidosis III | Knockout in HEK293T |
| MGAT1 | Cancer glycosylation | Overexpression in cancer cell lines |
| B4GALT1 | Glycosylation disorders | Point mutation knock-in |
| TRIP11 | Golgi positioning defects | Knockout in RPE1 cells |
Mucolipidoses and glycosylation disorders
Mucolipidoses are lysosomal storage diseases caused by defects in enzymes that target lysosomal hydrolases, many of which transit through the cis-Golgi network. Mutations in GNPTAB cause mucolipidosis II and III, highlighting the importance of cis-Golgi network function in human health.
Cancer and altered glycosylation
Altered glycosylation is a hallmark of cancer, and glycosyltransferases that act in the cis-Golgi network, such as MGAT1 and B4GALT1, are often dysregulated in tumors. Targeting these enzymes is an active area of cancer research.
Neurodegeneration and trafficking defects
Defects in Golgi trafficking, including at the cis-Golgi network, have been implicated in neurodegenerative diseases, although the exact mechanisms remain under investigation. Tethering factors like TUG are being studied for their roles in neuronal secretion.
From cis-Golgi network-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TRIP11 disrupt Golgi positioning? | TRIP11 knockout in RPE1 cells |
| How does TUG organize the early secretory pathway? | TUG knockout or tagged knock-in in HeLa cells |
| What is the role of GNPTAB in mucolipidosis? | GNPTAB knockout in patient fibroblasts |
| How does brefeldin A affect cis-Golgi network proteins? | Overexpression of tagged GMAP-210 in COS cells |
| Does MGAT1 overexpression alter glycosylation? | MGAT1 overexpression in cancer cell lines |
| What is the dynamics of plant cis-Golgi network? | Live imaging of Arabidopsis root cells |
How to Study the cis-Golgi network Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Cis-Golgi network morphology and protein localization | Golgi positioning studies |
| Live-cell imaging | Dynamic tubular network in plants | ER-to-Golgi trafficking |
| Proteomics | Protein composition of cis-Golgi network | Identifying novel components |
| Glycan mass spectrometry | N- and O-glycan structures | Glycosylation disorders |
| CRISPR knockout screens | Genes required for Golgi function | Discovery of regulators |
| Brefeldin A treatment | Redistribution of peripheral proteins | Golgi disassembly assays |
| Immunoprecipitation | Protein-protein interactions | Tethering complex analysis |
Fluorescence microscopy and live imaging
Fluorescence microscopy using markers such as GMAP-210 or golgins allows visualization of cis-Golgi network morphology and dynamics. Live imaging in plants has revealed the dynamic tubular network connecting ER and Golgi.
Proteomics and interactomics
Proteomic approaches can identify proteins associated with the cis-Golgi network, such as GMAP-210 and TUG, and their interaction partners. These methods help define the molecular composition of the compartment.
Glycosylation analysis
Mass spectrometry and lectin-based assays measure glycan structures modified in the cis-Golgi network, providing readouts for glycosyltransferase activity. These are used to study glycosylation disorders.
CRISPR screens
Genome-wide CRISPR knockout screens can identify genes required for cis-Golgi network organization and function, such as tethering factors. These screens are powerful for discovering novel regulators.
How CRISPR Can Be Used to Study GO:0005801 cis-Golgi network
Knockout
CRISPR knockout of cis-Golgi network genes such as TRIP11 or ASPSCR1 can reveal their roles in Golgi positioning and secretion. Knockout models are used to study loss-of-function phenotypes in human cells.
Point Mutation
Point mutations in glycosyltransferase genes like MGAT1 can mimic disease-associated alleles and help dissect catalytic activity. These models are valuable for understanding glycosylation disorders.
Knock-in
Knock-in of tagged proteins, such as GFP-tagged GMAP-210, allows live imaging of the cis-Golgi network. This approach is used to track dynamic changes in response to brefeldin A.
Overexpression
Overexpression of cis-Golgi network proteins like TUG or GMAP-210 can test sufficiency in organizing the early secretory pathway. Overexpression models are also used to study glycosyltransferases in cancer.
How EDITGENE Supports cis-Golgi network Research
Researchers studying cis-Golgi network-related genes often need to determine whether a candidate gene is causally involved in Golgi organization, glycosylation, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for cis-Golgi network research.
Frequently Asked Questions About cis-Golgi network
What is the cis-Golgi network?
The cis-Golgi network (GO:0005801) is the network of interconnected tubular and cisternal structures at the convex side of the Golgi apparatus, abutting the endoplasmic reticulum.
What genes are involved in the cis-Golgi network?
Key genes include TRIP11 (GMAP-210), ASPSCR1 (TUG), COPA, COPB1, GOLGA2, and glycosyltransferases such as MGAT1 and B4GALT1.
What is the function of the cis-Golgi network?
It serves as the entry point for ER-to-Golgi cargo, initiates glycosylation, and sorts proteins for further trafficking.
How is the cis-Golgi network positioned in cells?
It is positioned by microtubule-binding proteins such as GMAP-210, which binds minus-end microtubules.
What diseases are associated with the cis-Golgi network?
Mucolipidoses and other glycosylation disorders are linked to defects in cis-Golgi network enzymes like GNPTAB.
What is the role of TUG in the cis-Golgi network?
TUG (ASPSCR1) is a tethering factor that organizes the early secretory pathway at the cis-Golgi network.
How can I study the cis-Golgi network using CRISPR?
CRISPR knockout, knock-in, and overexpression models allow functional dissection of cis-Golgi network genes.
What is the difference between cis-Golgi network and cis-Golgi?
The cis-Golgi network is the specific network of tubular and cisternal structures at the cis face, while cis-Golgi broadly refers to the cis-most Golgi compartment.
What methods are used to study the cis-Golgi network?
Fluorescence microscopy, live imaging, proteomics, glycosylation analysis, and CRISPR screens are commonly used.
Why is the cis-Golgi network important for glycosylation?
It contains glycosyltransferases that initiate and extend glycans on secretory proteins.
Conclusion
The cis-Golgi network (GO:0005801) is a dynamic and essential compartment at the interface between the endoplasmic reticulum and the Golgi apparatus. Its components, including GMAP-210, TUG, and glycosyltransferases, are critical for protein sorting, glycosylation, and cellular homeostasis. Dysregulation of these processes is linked to human diseases such as mucolipidoses. Continued research using CRISPR models and advanced imaging will further illuminate the mechanisms of cis-Golgi network function and its role in health and disease.
References
- 1. Fougère L et al.. 2025. ER-to-Golgi trafficking through a dynamic intermediate cis-Golgi tubular network in Arabidopsis.. Nat Cell Biol 27(3):424-437 PMID: 40000850
- 2. Robinson DG. 2020. Plant Golgi ultrastructure.. J Microsc 280(2):111-121 PMID: 32420623
- 3. Stanley P. 2011. Golgi glycosylation.. Cold Spring Harb Perspect Biol 3(4) PMID: 21441588
- 4. Infante C et al.. 1999. GMAP-210, A cis-Golgi network-associated protein, is a minus end microtubule-binding protein.. J Cell Biol 145(1):83-98 PMID: 10189370
- 5. Jackson CL. 2014. GEF-effector interactions.. Cell Logist 4(2):e943616 PMID: 25610717
- 6. Parchure A et al.. 2025. TUG protein acts through a disordered region to organize the early secretory pathway.. Nat Commun 16(1):5518 PMID: 40593538
- 7. Rios RM et al.. 1994. A peripheral protein associated with the cis-Golgi network redistributes in the intermediate compartment upon brefeldin A treatment.. J Cell Biol 125(5):997-1013 PMID: 8195302
- 8. Khan SA et al.. 2020. Mucolipidoses Overview: Past, Present, and Future.. Int J Mol Sci 21(18) PMID: 32957425
